Filing Details

Accession Number:
0001062993-21-011407
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-22 20:39:55
Reporting Period:
2021-11-18
Accepted Time:
2021-11-22 20:39:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661181 Organogenesis Holdings Inc. ORGO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757452 Gn 2016 Organo 10-Year Grat U/A/D September 30, 2016 35 Sawgrass Drive
Bellport NY 11713
No No Yes No
1757453 Gn 2016 Family Trust U/A/D August 12, 2016 35 Sawgrass Drive
Bellport NY 11713
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-11-18 25,000 $9.93 59,448,027 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported securities were purchased and held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below).
  2. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $9.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. Reflects the total number of securities held by the Group.